{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:29:33Z","timestamp":1793820573513,"version":"4.6.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","award":["Brigitte Schlieben Lange Programm"],"award-info":[{"award-number":["Brigitte Schlieben Lange Programm"]}],"id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1453"],"award-info":[{"award-number":["CRC1453"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1453"],"award-info":[{"award-number":["CRC1453"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC1453"],"award-info":[{"award-number":["CRC1453"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021729","name":"Faculty of Medicine, University of Freiburg","doi-asserted-by":"crossref","award":["Berta Ottenstein Programm"],"award-info":[{"award-number":["Berta Ottenstein Programm"]}],"id":[{"id":"10.13039\/501100021729","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inactivation of the tumor suppressor von Hippel\u2013Lindau (<jats:italic>VHL<\/jats:italic>) gene is a key event in hereditary and sporadic clear cell renal cell carcinomas (ccRCC). The mechanistic target of rapamycin (mTOR) signaling pathway is a fundamental regulator of cell growth and proliferation, and hyperactivation of mTOR signaling is a common finding in VHL-dependent ccRCC. Deregulation of mTOR signaling correlates with tumor progression and poor outcome in patients with ccRCC. Here, we report that the regulatory-associated protein of mTOR (RAPTOR) is strikingly repressed by VHL. VHL interacts with RAPTOR and increases RAPTOR degradation by ubiquitination, thereby inhibiting mTORC1 signaling. Consistent with hyperactivation of mTORC1 signaling in VHL-deficient ccRCC, we observed that loss of <jats:italic>vhl-1<\/jats:italic> function in <jats:italic>C. elegans<\/jats:italic> increased mTORC1 activity, supporting an evolutionary conserved mechanism. Our work reveals important new mechanistic insight into deregulation of mTORC1 signaling in ccRCC and links VHL directly to the control of RAPTOR\/mTORC1. This may represent a novel mechanism whereby loss of VHL affects organ integrity and tumor behavior.<\/jats:p>","DOI":"10.1038\/s41598-021-94132-5","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T10:07:53Z","timestamp":1626862073000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["VHL suppresses RAPTOR and inhibits mTORC1 signaling in clear cell renal cell carcinoma"],"prefix":"10.1038","volume":"11","author":[{"given":"Athina","family":"Ganner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gehrke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinella","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Thegtmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Matulenski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Wingendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicitas","family":"Pilz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Greidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Meid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fruzsina","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J.","family":"Frew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Neumann-Haefelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"94132_CR1","doi-asserted-by":"crossref","unstructured":"Global Burden of Disease Cancer, C., et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: A systematic analysis for the global burden of disease study. JAMA Oncol. 5, 1749\u20131768 (2019).","DOI":"10.1001\/jamaoncol.2019.2996"},{"key":"94132_CR2","unstructured":"Clark, D.J., et al. Integrated proteogenomic characterization of clear cell renal cell carcinoma. Cell 179, 964\u2013983 e931 (2019)."},{"key":"94132_CR3","doi-asserted-by":"publisher","first-page":"3698","DOI":"10.1016\/j.celrep.2018.06.032","volume":"23","author":"CJ Ricketts","year":"2018","unstructured":"Ricketts, C. J. et al. The Cancer genome atlas comprehensive molecular characterization of renal cell carcinoma. Cell Rep. 23, 3698 (2018).","journal-title":"Cell Rep."},{"key":"94132_CR4","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Research, N. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43\u201349 (2013).","DOI":"10.1038\/nature12222"},{"key":"94132_CR5","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ng.2699","volume":"45","author":"Y Sato","year":"2013","unstructured":"Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860\u2013867 (2013).","journal-title":"Nat. Genet."},{"key":"94132_CR6","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1002\/cncr.22677","volume":"109","author":"AJ Pantuck","year":"2007","unstructured":"Pantuck, A. J. et al. Prognostic relevance of the mTOR pathway in renal cell carcinoma: Implications for molecular patient selection for targeted therapy. Cancer 109, 2257\u20132267 (2007).","journal-title":"Cancer"},{"key":"94132_CR7","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.juro.2006.08.076","volume":"177","author":"VA Robb","year":"2007","unstructured":"Robb, V. A., Karbowniczek, M., Klein-Szanto, A. J. & Henske, E. P. Activation of the mTOR signaling pathway in renal clear cell carcinoma. J. Urol. 177, 346\u2013352 (2007).","journal-title":"J. Urol."},{"key":"94132_CR8","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.trecan.2016.03.008","volume":"2","author":"E Ilagan","year":"2016","unstructured":"Ilagan, E. & Manning, B. D. Emerging role of mTOR in the response to cancer therapeutics. Trends in cancer 2, 241\u2013251 (2016).","journal-title":"Trends in cancer"},{"key":"94132_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.gde.2012.12.005","volume":"23","author":"M Cornu","year":"2013","unstructured":"Cornu, M., Albert, V. & Hall, M. N. mTOR in aging, metabolism, and cancer. Curr. Opin. Genet. Dev. 23, 53\u201362 (2013).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"94132_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41580-019-0199-y","volume":"21","author":"GY Liu","year":"2020","unstructured":"Liu, G. Y. & Sabatini, D. M. mTOR at the nexus of nutrition, growth, ageing and disease. Nat. Rev. Mol. Cell Biol. 21, 183\u2013203 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"94132_CR11","doi-asserted-by":"crossref","unstructured":"Zhang, Y., et al. A Pan-Cancer Proteogenomic Atlas of PI3K\/AKT\/mTOR Pathway Alterations. Cancer cell 31, 820\u2013832 e823 (2017).","DOI":"10.1016\/j.ccell.2017.04.013"},{"key":"94132_CR12","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aad5755","volume":"353","author":"J Guo","year":"2016","unstructured":"Guo, J. et al. pVHL suppresses kinase activity of Akt in a proline-hydroxylation-dependent manner. Science 353, 929\u2013932 (2016).","journal-title":"Science"},{"key":"94132_CR13","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1101\/gad.1256804","volume":"18","author":"J Brugarolas","year":"2004","unstructured":"Brugarolas, J. et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex. Genes Dev. 18, 2893\u20132904 (2004).","journal-title":"Genes Dev."},{"key":"94132_CR14","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1158\/1541-7786.MCR-11-0302","volume":"9","author":"B Kucejova","year":"2011","unstructured":"Kucejova, B. et al. Interplay between pVHL and mTORC1 pathways in clear-cell renal cell carcinoma. Mol. Cancer Res. MCR 9, 1255\u20131265 (2011).","journal-title":"Mol. Cancer Res. MCR"},{"key":"94132_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.molcel.2012.09.017","volume":"48","author":"A Elorza","year":"2012","unstructured":"Elorza, A. et al. HIF2alpha acts as an mTORC1 activator through the amino acid carrier SLC7A5. Mol. Cell 48, 681\u2013691 (2012).","journal-title":"Mol. Cell"},{"key":"94132_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.isci.2019.10.047","volume":"21","author":"H Doan","year":"2019","unstructured":"Doan, H. et al. HIF-mediated suppression of DEPTOR confers resistance to mTOR kinase inhibition in renal cancer. iScience 21, 509\u2013520 (2019).","journal-title":"iScience"},{"key":"94132_CR17","doi-asserted-by":"publisher","first-page":"5679","DOI":"10.1038\/s41467-019-13528-0","volume":"10","author":"F Chen","year":"2019","unstructured":"Chen, F., Chandrashekar, D. S., Varambally, S. & Creighton, C. J. Pan-cancer molecular subtypes revealed by mass-spectrometry-based proteomic characterization of more than 500 human cancers. Nat. Commun. 10, 5679 (2019).","journal-title":"Nat. Commun."},{"key":"94132_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm0895-822","volume":"1","author":"O Iliopoulos","year":"1995","unstructured":"Iliopoulos, O., Kibel, A., Gray, S. & Kaelin, W. G. Jr. Tumour suppression by the human von Hippel\u2013Lindau gene product. Nat. Med. 1, 822\u2013826 (1995).","journal-title":"Nat. Med."},{"key":"94132_CR19","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.7660130","volume":"269","author":"A Kibel","year":"1995","unstructured":"Kibel, A., Iliopoulos, O., DeCaprio, J. A. & Kaelin, W. G. Jr. Binding of the von Hippel\u2013Lindau tumor suppressor protein to Elongin B and C. Science 269, 1444\u20131446 (1995).","journal-title":"Science"},{"key":"94132_CR20","doi-asserted-by":"publisher","first-page":"12436","DOI":"10.1073\/pnas.96.22.12436","volume":"96","author":"K Iwai","year":"1999","unstructured":"Iwai, K. et al. Identification of the von Hippel\u2013Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc. Natl. Acad. Sci. U.S.A. 96, 12436\u201312441 (1999).","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"94132_CR21","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1126\/science.1157535","volume":"320","author":"Y Sancak","year":"2008","unstructured":"Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496\u20131501 (2008).","journal-title":"Science"},{"key":"94132_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1471-2121-14-3","volume":"14","author":"RB Yadav","year":"2013","unstructured":"Yadav, R. B. et al. mTOR direct interactions with Rheb-GTPase and raptor: Sub-cellular localization using fluorescence lifetime imaging. BMC Cell Biol. 14, 3 (2013).","journal-title":"BMC Cell Biol."},{"key":"94132_CR23","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/1097-0215(20010215)91:4<457::AID-IJC1072>3.0.CO;2-P","volume":"91","author":"AR Schoenfeld","year":"2001","unstructured":"Schoenfeld, A. R., Davidowitz, E. J. & Burk, R. D. Endoplasmic reticulum\/cytosolic localization of von Hippel\u2013Lindau gene products is mediated by a 64-amino acid region. Int. J. Cancer 91, 457\u2013467 (2001).","journal-title":"Int. J. Cancer"},{"key":"94132_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage, L., Eisen, T. & Maher, E. R. VHL, the story of a tumour suppressor gene. Nat. Rev. Cancer 15, 55\u201364 (2015).","journal-title":"Nat. Rev. Cancer"},{"key":"94132_CR25","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/sj.onc.1209062","volume":"25","author":"K Knauth","year":"2006","unstructured":"Knauth, K., Bex, C., Jemth, P. & Buchberger, A. Renal cell carcinoma risk in type 2 von Hippel\u2013Lindau disease correlates with defects in pVHL stability and HIF-1alpha interactions. Oncogene 25, 370\u2013377 (2006).","journal-title":"Oncogene"},{"key":"94132_CR26","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1038\/s41591-020-1093-z","volume":"26","author":"TK Choueiri","year":"2020","unstructured":"Choueiri, T. K. & Kaelin, W. G. Jr. Targeting the HIF2-VEGF axis in renal cell carcinoma. Nat. Med. 26, 1519\u20131530 (2020).","journal-title":"Nat. Med."},{"key":"94132_CR27","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1158\/0008-5472.CAN-16-0473","volume":"76","author":"EM Wallace","year":"2016","unstructured":"Wallace, E. M. et al. A small-molecule antagonist of HIF2alpha Is efficacious in preclinical models of renal cell carcinoma. Can. Res. 76, 5491\u20135500 (2016).","journal-title":"Can. Res."},{"key":"94132_CR28","doi-asserted-by":"publisher","first-page":"e2843","DOI":"10.1038\/cddis.2017.235","volume":"8","author":"HS Ban","year":"2017","unstructured":"Ban, H. S. et al. The novel hypoxia-inducible factor-1alpha inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth. Cell Death Dis. 8, e2843 (2017).","journal-title":"Cell Death Dis."},{"key":"94132_CR29","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1534\/genetics.119.302504","volume":"213","author":"TK Blackwell","year":"2019","unstructured":"Blackwell, T. K., Sewell, A. K., Wu, Z. & Han, M. TOR signaling in Caenorhabditis elegans development, metabolism, and aging. Genetics 213, 329\u2013360 (2019).","journal-title":"Genetics"},{"key":"94132_CR30","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1681\/ASN.2009050497","volume":"20","author":"RU Muller","year":"2009","unstructured":"Muller, R. U. et al. The von Hippel Lindau tumor suppressor limits longevity. J. Am. Soc. Nephrol. 20, 2513\u20132517 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"94132_CR31","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1126\/science.1173507","volume":"324","author":"R Mehta","year":"2009","unstructured":"Mehta, R. et al. Proteasomal regulation of the hypoxic response modulates aging in C. elegans. Science 324, 1196\u20131198 (2009).","journal-title":"Science"},{"key":"94132_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00441-017-2622-z","volume":"369","author":"A Ganner","year":"2017","unstructured":"Ganner, A. & Neumann-Haefelin, E. Genetic kidney diseases: Caenorhabditis elegans as model system. Cell Tissue Res. 369, 105\u2013118 (2017).","journal-title":"Cell Tissue Res."},{"key":"94132_CR33","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature20789","volume":"541","author":"C Heintz","year":"2017","unstructured":"Heintz, C. et al. Splicing factor 1 modulates dietary restriction and TORC1 pathway longevity in C. elegans. Nature 541, 102\u2013106 (2017).","journal-title":"Nature"},{"key":"94132_CR34","doi-asserted-by":"publisher","first-page":"10944","DOI":"10.1038\/ncomms10944","volume":"7","author":"S Nakamura","year":"2016","unstructured":"Nakamura, S. et al. Mondo complexes regulate TFEB via TOR inhibition to promote longevity in response to gonadal signals. Nat. Commun. 7, 10944 (2016).","journal-title":"Nat. Commun."},{"key":"94132_CR35","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1242\/dev.01255","volume":"131","author":"K Jia","year":"2004","unstructured":"Jia, K., Chen, D. & Riddle, D. L. The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span. Development 131, 3897\u20133906 (2004).","journal-title":"Development"},{"key":"94132_CR36","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.1371\/journal.pgen.0040024","volume":"4","author":"M Hansen","year":"2008","unstructured":"Hansen, M. et al. A role for autophagy in the extension of lifespan by dietary restriction in C. elegans. PLoS Genet. 4, e24 (2008).","journal-title":"PLoS Genet."},{"key":"94132_CR37","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/cr.2013.168","volume":"24","author":"Y Feng","year":"2014","unstructured":"Feng, Y., He, D., Yao, Z. & Klionsky, D. J. The machinery of macroautophagy. Cell Res. 24, 24\u201341 (2014).","journal-title":"Cell Res."},{"key":"94132_CR38","doi-asserted-by":"publisher","first-page":"e15460","DOI":"10.1371\/journal.pone.0015460","volume":"5","author":"SJ Gosai","year":"2010","unstructured":"Gosai, S. J. et al. Automated high-content live animal drug screening using C. elegans expressing the aggregation prone serpin alpha1-antitrypsin Z. PloS One 5, e15460 (2010).","journal-title":"PloS One"},{"key":"94132_CR39","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"DM Gwinn","year":"2008","unstructured":"Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214\u2013226 (2008).","journal-title":"Mol. Cell"},{"key":"94132_CR40","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","volume":"14","author":"DD Sarbassov","year":"2004","unstructured":"Sarbassov, D. D. et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol.CB 14, 1296\u20131302 (2004).","journal-title":"Curr. Biol.CB"},{"key":"94132_CR41","first-page":"ra25","volume":"5","author":"P Dalle Pezze","year":"2012","unstructured":"Dalle Pezze, P. et al. A dynamic network model of mTOR signaling reveals TSC-independent mTORC2 regulation. Sci. Signal. 5, ra25 (2012).","journal-title":"Sci. Signal."},{"key":"94132_CR42","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aap8411","volume":"361","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science 361, 290\u2013295 (2018).","journal-title":"Science"},{"key":"94132_CR43","doi-asserted-by":"crossref","unstructured":"Liu, X., et al. Genome-wide screening identifies SFMBT1 as an oncogenic driver in cancer with VHL loss. Molecular cell 77, 1294\u20131306 e1295 (2020).","DOI":"10.1016\/j.molcel.2020.01.009"},{"key":"94132_CR44","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1126\/science.1162981","volume":"321","author":"JH Mao","year":"2008","unstructured":"Mao, J. H. et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321, 1499\u20131502 (2008).","journal-title":"Science"},{"key":"94132_CR45","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2016.11.031","volume":"388","author":"FF Wang","year":"2017","unstructured":"Wang, F. F. et al. FBX8 is a metastasis suppressor downstream of miR-223 and targeting mTOR for degradation in colorectal carcinoma. Cancer Lett. 388, 85\u201395 (2017).","journal-title":"Cancer Lett."},{"key":"94132_CR46","doi-asserted-by":"publisher","first-page":"14120","DOI":"10.1074\/jbc.M114.633057","volume":"290","author":"J Koo","year":"2015","unstructured":"Koo, J., Wu, X., Mao, Z., Khuri, F. R. & Sun, S. Y. Rictor undergoes glycogen synthase kinase 3 (GSK3)-dependent, FBXW7-mediated ubiquitination and proteasomal degradation. J. Biol. Chem. 290, 14120\u201314129 (2015).","journal-title":"J. Biol. Chem."},{"key":"94132_CR47","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/j.bbrc.2014.07.035","volume":"450","author":"SI Choi","year":"2014","unstructured":"Choi, S. I., Maeng, Y. S., Kim, K. S., Kim, T. I. & Kim, E. K. Autophagy is induced by raptor degradation via the ubiquitin\/proteasome system in granular corneal dystrophy type 2. Biochem. Biophys. Res. Commun. 450, 1505\u20131511 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94132_CR48","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1128\/MCB.01389-12","volume":"33","author":"S Hussain","year":"2013","unstructured":"Hussain, S. et al. Ubiquitin hydrolase UCH-L1 destabilizes mTOR complex 1 by antagonizing DDB1-CUL4-mediated ubiquitination of raptor. Mol. Cell. Biol. 33, 1188\u20131197 (2013).","journal-title":"Mol. Cell. Biol."},{"key":"94132_CR49","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nature22344","volume":"545","author":"B Wang","year":"2017","unstructured":"Wang, B. et al. TRAF2 and OTUD7B govern a ubiquitin-dependent switch that regulates mTORC2 signalling. Nature 545, 365\u2013369 (2017).","journal-title":"Nature"},{"key":"94132_CR50","doi-asserted-by":"publisher","first-page":"373","DOI":"10.4161\/cc.7.3.5267","volume":"7","author":"P Ghosh","year":"2008","unstructured":"Ghosh, P., Wu, M., Zhang, H. & Sun, H. mTORC1 signaling requires proteasomal function and the involvement of CUL4-DDB1 ubiquitin E3 ligase. Cell Cycle 7, 373\u2013381 (2008).","journal-title":"Cell Cycle"},{"key":"94132_CR51","doi-asserted-by":"publisher","first-page":"12605","DOI":"10.1038\/srep12605","volume":"5","author":"G Minervini","year":"2015","unstructured":"Minervini, G. et al. Isoform-specific interactions of the von Hippel\u2013Lindau tumor suppressor protein. Sci. Rep. 5, 12605 (2015).","journal-title":"Sci. Rep."},{"key":"94132_CR52","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molcel.2006.04.006","volume":"22","author":"JS Roe","year":"2006","unstructured":"Roe, J. S. et al. p53 stabilization and transactivation by a von Hippel\u2013Lindau protein. Mol. Cell 22, 395\u2013405 (2006).","journal-title":"Mol. Cell"},{"key":"94132_CR53","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1016\/j.ejca.2013.02.024","volume":"49","author":"IJ Frew","year":"2013","unstructured":"Frew, I. J., Smole, Z., Thoma, C. R. & Krek, W. Genetic deletion of the long isoform of the von Hippel\u2013Lindau tumour suppressor gene product alters microtubule dynamics. Eur. J. Cancer 49, 2433\u20132440 (2013).","journal-title":"Eur. J. Cancer"},{"key":"94132_CR54","doi-asserted-by":"publisher","first-page":"25733","DOI":"10.1074\/jbc.M002740200","volume":"275","author":"ME Cockman","year":"2000","unstructured":"Cockman, M. E. et al. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel\u2013Lindau tumor suppressor protein. J. Biol. Chem. 275, 25733\u201325741 (2000).","journal-title":"J. Biol. Chem."},{"key":"94132_CR55","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nature00767","volume":"417","author":"WC Hon","year":"2002","unstructured":"Hon, W. C. et al. Structural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHL. Nature 417, 975\u2013978 (2002).","journal-title":"Nature"},{"key":"94132_CR56","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min, J. H. et al. Structure of an HIF-1alpha -pVHL complex: Hydroxyproline recognition in signaling. Science 296, 1886\u20131889 (2002).","journal-title":"Science"},{"key":"94132_CR57","doi-asserted-by":"publisher","first-page":"4266","DOI":"10.1074\/jbc.274.7.4266","volume":"274","author":"M Vilella-Bach","year":"1999","unstructured":"Vilella-Bach, M., Nuzzi, P., Fang, Y. & Chen, J. The FKBP12-rapamycin-binding domain is required for FKBP12-rapamycin-associated protein kinase activity and G1 progression. J. Biol. Chem. 274, 4266\u20134272 (1999).","journal-title":"J. Biol. Chem."},{"key":"94132_CR58","doi-asserted-by":"crossref","unstructured":"Viau, A., et al. Cilia-localized LKB1 regulates chemokine signaling, macrophage recruitment, and tissue homeostasis in the kidney. EMBO J. 37, e98615 (2018).","DOI":"10.15252\/embj.201798615"},{"key":"94132_CR59","doi-asserted-by":"publisher","first-page":"e0130275","DOI":"10.1371\/journal.pone.0130275","volume":"10","author":"H Ramachandran","year":"2015","unstructured":"Ramachandran, H., Herfurth, K., Grosschedl, R., Schafer, T. & Walz, G. SUMOylation Blocks the Ubiquitin-Mediated Degradation of the Nephronophthisis Gene Product Glis2\/NPHP7. PloS One 10, e0130275 (2015).","journal-title":"PloS One"},{"key":"94132_CR60","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbrc.2020.02.006","volume":"524","author":"A Ganner","year":"2020","unstructured":"Ganner, A. et al. The acetyltransferase p300 regulates NRF2 stability and localization. Biochem. Biophys. Res. Commun. 524, 895\u2013902 (2020).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"94132_CR61","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/ncb1912","volume":"11","author":"CR Thoma","year":"2009","unstructured":"Thoma, C. R. et al. VHL loss causes spindle misorientation and chromosome instability. Nat. Cell Biol. 11, 994\u20131001 (2009).","journal-title":"Nat. Cell Biol."},{"key":"94132_CR62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/ncb1579","volume":"9","author":"CR Thoma","year":"2007","unstructured":"Thoma, C. R. et al. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network. Nat. Cell Biol. 9, 588\u2013595 (2007).","journal-title":"Nat. Cell Biol."},{"key":"94132_CR63","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/ng1552","volume":"37","author":"M Simons","year":"2005","unstructured":"Simons, M. et al. Inversin, the gene product mutated in nephronophthisis type II, functions as a molecular switch between Wnt signaling pathways. Nat. Genet. 37, 537\u2013543 (2005).","journal-title":"Nat. Genet."},{"key":"94132_CR64","doi-asserted-by":"publisher","first-page":"8957","DOI":"10.1128\/JVI.77.16.8957-8951.2003","volume":"77","author":"M Wiznerowicz","year":"2003","unstructured":"Wiznerowicz, M. & Trono, D. Conditional suppression of cellular genes: Lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957\u20138961 (2003).","journal-title":"J. Virol."},{"key":"94132_CR65","doi-asserted-by":"publisher","first-page":"RESEARCH0002","DOI":"10.1186\/gb-2001-2-2-reports0002","volume":"2","author":"RS Kamath","year":"2001","unstructured":"Kamath, R. S., Martinez-Campos, M., Zipperlen, P., Fraser, A. G. & Ahringer, J. Effectiveness of specific RNA-mediated interference through ingested double-stranded RNA in Caenorhabditis elegans. Genome Biol. 2, RESEARCH0002 (2001).","journal-title":"Genome Biol."},{"key":"94132_CR66","doi-asserted-by":"crossref","unstructured":"Aspernig, H., et al. Mitochondrial Perturbations Couple mTORC2 to Autophagy in C. elegans. Cell Rep. 29, 1399\u20131409 e1395 (2019).","DOI":"10.1016\/j.celrep.2019.09.072"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94132-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94132-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T11:26:11Z","timestamp":1670066771000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-94132-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["94132"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-94132-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"15 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14827"}}